Subject
Translational Neurodegeneration is a peer-reviewed medical journal covering the field of neurodegenerative diseases, such as Parkinson's and Alzheimer's disease. It was established in 2012 and is published by BioMed Central. The editor-in-chief is Shengdi Chen (School of Medicine, Shanghai Jiao Tong University). Source: Wikipedia (en)
Editions published in Translational Neurodegeneration 200
Too many entities requested (295). Only 200 are displayed.
-
Better survival in female -mutant patients with ALS: a study of -related natural history
-
Transcranial direct current stimulation enhances theory of mind in Parkinson's disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study
-
Suppression of astrocytic autophagy by αB-crystallin contributes to α-synuclein inclusion formation
-
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy
-
Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease
-
Hydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer's disease
-
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
-
AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression.
-
Alzheimer's disease hypothesis and related therapies.
-
Hydrogen sulfide, nitric oxide, and neurodegenerative disorders.
-
Factors that influence adult neurogenesis as potential therapy.
-
The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms.
-
Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy.
-
Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer's dementia: a meta-analysis.
-
Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
-
Treating refractory depression in Parkinson's disease: a meta-analysis of transcranial magnetic stimulation.
-
Chinese expert consensus on programming deep brain stimulation for patients with Parkinson's disease.
-
Exercise-induced increase in brain-derived neurotrophic factor in human Parkinson's disease: a systematic review and meta-analysis.
-
Divergent topological networks in Alzheimer's disease: a diffusion kurtosis imaging analysis.
-
Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson’s disease.
-
Adjunct rasagiline to treat Parkinson’s disease with motor fluctuations: a randomized, double-blind study in China.
-
The role of substantia nigra sonography in the differentiation of Parkinson's disease and multiple system atrophy
-
Cognitive characteristics in Chinese non-demented PD patients based on gender difference
-
Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease
-
Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson's disease
-
Aberrant functional connectivity network in subjective memory complaint individuals relates to pathological biomarkers
-
Ultra-High Field Diffusion MRI Reveals Early Axonal Pathology in Spinal Cord of ALS mice
-
Neurodegeneration-associated FUS is a novel regulator of circadian gene expression
-
CSF Aβ level is associated with cognitive decline in early Parkinson's disease with rapid eye movement sleep behavior disorder
-
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
-
Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons
-
Bis(9)-(-)-Meptazinol, a novel dual-binding AChE inhibitor, rescues cognitive deficits and pathological changes in APP/PS1 transgenic mice
Subject - wd:Q18216027